The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A03 | Drugs for functional gastrointestinal disorders | |
| 3 | A03B | BELLADONNA AND DERIVATIVES, PLAIN | |
| 4 | A03BA | Belladonna alkaloids, tertiary amines |
| Code | Title | |
|---|---|---|
| A03BA01 | Atropine | |
| A03BA03 | Hyoscyamine | |
| A03BA04 | Belladonna total alkaloids |
| Active Ingredient | Description | |
|---|---|---|
| Atropine |
Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system. |
|
| Hyoscyamine |
Hyoscyamine inhibits specifically the actions of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. Hyoscyamine inhibits gastrointestinal propulsive motility and decreases gastric acid secretion. It also controls excessive pharyngeal, tracheal and bronchial secretions. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ATROPINE Eye drops | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ATROPINE Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| ATROPINE Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
